Interesting that in the accounts what drove the -A$161M EBIT result
Non-cash items -A$68M for Dep/Amortisation and -A$82.7M for earn out reassessment (see below) and cash item of A$33.2M Class action.
Management must be very confident in the increased revenue forecast for TXMD products to increase future royalties payable by that much.
Total royalties liabilities for the life of the products has now increased from A$296M to A$382M.
Interesting that in the accounts what drove the -A$161M EBIT...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.20 |
Change
-0.140(2.62%) |
Mkt cap ! $422.4M | |||
| Open | High | Low | Value | Volume |
| $5.33 | $5.35 | $5.20 | $1.224M | 232.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2494 | $5.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.26 | 6000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |